Brain cancer drug developer NeOnc Technologies (NTHI) plans to go public via a direct listing, roughly six months after pulling its IPO. Read more here.
In today’s fast-paced world, maintaining optimal cognitive function has become paramount. Whether juggling work deadlines, managing personal responsibilities, or simply striving to maintain a sharp ...